Page 46 - journal-8-23-Full
P. 46

38   «“√ “√°“√·æ∑¬·º “√  ‰ ¬·≈– ° √·æ ∑“ß“  ∑¬                               ªï∑’Ë 9©∫—∫∑’Ë 1 ¡°√“§¡- ‘ßÀ“§¡ 2554
                 “√°“√ ∑¬å·º ‰ ¬·≈–°“√ æ∑¬∑“å·ºπ‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ°
                  °“√ ∑¬åå·ºπ‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ°
             «“√ “√°“√·æ∑¬


                 Abstract
                     Acute and Chronic Toxicity Study of Benjathiposoth Extract
                     Songpol Chivapat*, Pornchai Sincharoenpokai*, Pranee Chavalittumrong †
                                                †
                     *Medicinal Plant Research Institute,  Senior Technical Office, Department of Medical Sciences, Ministry of Public
                     Health, Nonthaburi
                         A Thai traditional medicine called Benjathiposoth has been reported to possess hypotensive activity.  The
                     recipe for preparing medication contains 10 types of herbal materials.  An acute toxicity study in mice by
                     gavaging the ethanolic extract of Benjathiposoth at single doses of 2.5, 5.0 and 10.0 g/kg showed that the
                     extract produced neither abnormal signs nor mortality and its LD  value was more than 10.0 g/kg, which is
                                                                        50
                     approximately 1,000 times greater than the human therapeutic dose. The oral six-month chronic toxicity
                     study of the extract was investigated in 144 Wistar rats divided into six groups (each of 12 per sex).  Groups 1
                     and 2 were control groups given with distilled water orally and 1.0% tragacanth solution respectively. Groups
                     3 to 6 were experimental groups administered orally extract of Benjathiposoth at doses of 10, 100, 500 and 500
                     mg/kg/day.  After six months, the last group (500-R) was further raised without the extract for two weeks in
                     order to assess reversibility of any adverse effects. The results revealed that the Benjathiposoth extract did not
                     affect growth, food intake, health and behaviors of the test animals.  The extract at the doses given caused no
                     significant differences in any hematological parameters between the treatment and control groups.  Clinical
                     chemistry assays revealed a significant increase in total serum protein in the female group treated with the
                     highest dose of the extract, which was still within the reference interval of normal rats, whereas other param-
                     eters showed no significant deviation from the controls.  Histopathology of various visceral organs showed
                     that the male groups receiving the extract at 100 mg/kg and higher have a higher incidence of fatty liver.
                     Moreover, these male groups as well as the 500-R group, had higher incidence of kidney congestion when
                     compared with their corresponding control groups. Nevertheless, no pathological change was found in glom-
                     erular and tubular kidneys. The incidence of histopathological findings in some organs did not show any dose
                     dependency; therefore, it was considered as not having been contributed by the extract. In summary, the
                     extract of Benjathiposoth produced no serious acute or chronic toxicity in experimental animals.
                     Key words:  Benjathiposoth, acute toxicity, chronic toxicity
   41   42   43   44   45   46   47   48   49   50   51